Do not use in horses as severe adverse reactions, including fatalities, will occur.
Do not use in dogs as severe adverse reactions may occur.
Do not use in cases of hypersensitivity to the active substances or to any of the excipients.
Do not exceed the recommended dose rate.
Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy:
Underdosing, which may be due to underestimation of bodyweight, misadministration of the product or lack of calibration of the dosing device.
Too frequent and repeated use of anthelmintics from the same class over an extended period of time.
Assess bodyweight as accurately as possible before calculating dosage. Suspected clinical cases of resistance should be further investigated using the appropriate tests, e.g. (Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used.
The recommended dose of Startect Dual Active is 0.2 ml/kg; doses of 0.9 ml/kg and higher (4.5X the recommended dose) can cause signs of toxicity and may lead to fatalities.
If animals are batched for dosing it is very important that careful consideration be given to the weight range within each group, to avoid the risk of overdosing smaller animals. A representative sample of animals should be weighed before treatment.
Accuracy and proper functioning of the dosage device should be checked.
The safety of Startect Dual Active has not been established in sheep under six weeks of age or weighing less than 10 kg.
Sheep:
Very common (>1 animal / 10 animals treated): | coughing1 |
1Mild transient.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system.
Doses of 0.9 ml/kg and higher have been associated with symptoms of toxicity. Signs of toxicity include dullness, depression, incoordination, weakness, decreased gastrointestinal motility and abnormal breathing pattern, recumbency and death. Non-fatal adverse events have been shown to be fully reversible. Supportive veterinary care is indicated; there is no known antidote.
User warnings
Do not eat, smoke or drink while handling the product.
Personal protective equipment consisting of impermeable rubber gloves should be worn when handling the veterinary medicinal product.
Avoid ingestion, inhalation and eye and skin contact. Wash hands after handling the product. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
In case of accidental eye or skin contact, wash affected areas immediately with clean running water and seek medical attention if irritation persists.
Withdrawal periods
Meat and offal: 14 days.
Milk: not authorised for use in animals producing milk for human consumption.